Neuromuscular diseases are a group of conditions that affect the muscles and nerves controlling them. These diseases can cause muscle weakness, paralysis, pain, impaired tendon reflexes, increased sensitivity to touch, and other muscle and nerve impairments. Common neuromuscular diseases include myasthenia gravis, muscular dystrophy, amyotrophic lateral sclerosis (ALS), and peripheral neuropathy. Myasthenia gravis is an autoimmune disease that affects the neuromuscular junction controlling muscle contraction. In this disease, the immune system fails to recognize the body's muscles, leading to muscle weakness. Muscular dystrophy is a genetic disorder that causes gradual weakening of the muscles. This is caused by defects or damage in the genes that control muscle development. ALS is a progressive motor neuron disease caused by degeneration of the nerve cells responsible for muscle control. In ALS, cells in the brain and spinal cord that control muscle movement start to die, leading to muscles wasting away. Peripheral neuropathy is a disorder that affects the peripheral nerves which are responsible for sending messages between the brain and other parts of the body. Symptoms can include weakness and numbness of the affected areas and can lead to difficulties in walking or coordinating movement. To diagnose neuromuscular diseases, medical professionals may conduct a physical examination and run a series of tests. These tests can include a nerve conduction study, electromyography (EMG), and muscle biopsies. Treatment for neuromuscular diseases is individualized based on the patient's symptoms and the severity of the condition.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Krishna Moorjani, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Abhay Murthy, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signalling
Ethan Liu, Boston University, United States